News
In Practice: Insulin supply changes
Supplies of Humulin and Humalog insulin vials are set to be discontinued from mid-2026.
From June 2026, only the cartridge presentations of Humulin and Humalog will be distributed in Australia.
This week’s In Practice also includes an on-demand recording available for healthcare professionals providing psychedelic-assisted psychotherapy for veterans, and current projects on the GP Research Noticeboard.
Humulin and Humalog vial discontinuation
GPs are reminded that manufacturer Eli Lilly is due to discontinue Humulin and Humalog vials from next year.
From June 2026, only the cartridge presentations of Humulin and Humalog will be distributed in Australia, with both removed from the market by 1 August. The Therapeutic Goods Administration (TGA) has now updated their availability status to be a ‘reduction in supply until supply is exhausted’
Information on the discontinuation is available on the TGA website for Humulin and Humalog.
Department of Veterans’ Affairs update
The Department of Veterans’ Affairs (DVA) recently announced that authorised psychiatrists can request funding for psychedelic-assisted psychotherapy using MDMA or psilocybin for eligible veterans with specific mental health conditions.
DVA Provider News has now published a recording of the 30 October clinician briefing on psychedelic-assisted psychotherapy.
GP Research Noticeboard
The GP Research Noticeboard presents surveys and research projects that GPs can participate in. Current projects listed include:
Members can also submit their research projects to the noticeboard to recruit participants from the general practice community.
Log in below to join the conversation.
diabetes medication GP research insulin medication shortages psychedelic assisted psychotherapy veterans’ health
newsGP weekly poll
Do you ever use the Pay Doctor Via Claimant (PDVC) cheque system when billing patients?